Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab

Eur J Cancer. 2018 Feb:90:146-148. doi: 10.1016/j.ejca.2017.11.008. Epub 2017 Dec 11.

¹ Department of Dermatology, Medical University of Graz, Austria.
² Department of Radiology, Division of General Radiology, Medical University of Graz, Austria.
³ Department of Pathology, Hospital Graz South-West, Austria.
⁴ Institute of Physiology, Medical University of Graz, Austria.
⁵ Department of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, Italy.
⁶ Dermatology Clinic, Maggiore Hospital, University of Trieste, Italy. Electronic address: [email protected].

No abstract available

Publication types